Exocytosis is the process by which stored neurotransmitters and hormones are released via the fusion of secretory vesicles with the plasma membrane. It is a dynamic, rapid and spatially restricted process involving multiple steps including vesicle trafficking, tethering, docking, priming and fusion. For many years great steps have been undertaken in our understanding of how exocytosis occurs in different cell types, with significant focus being placed on synaptic release and neurotransmission. However, this process of exocytosis is an essential component of cell signalling throughout the body and underpins a diverse array of essential physiological pathways. Many similarities exist between different cell types with regard to key aspects of the exocytosis pathway, such as the need for Ca This article is part of a mini review series on Chromaffin cells (ISCCB Meeting, 2015).
Regulated exocytosis in endocrine and gliocrine secretory cellsRegulated exocytosis consists of many stages, including the one where the membrane of a vesicle, laden with hormones, transmitters and chemical messengers, merges with the plasma membrane (Fig. 1). This universal process of eukaryotic cells is an evolutionary invention, which emerged from a prokaryotic-like precursor cell by endosymbiosis Address correspondence and reprint requests to Professor Damien Keating, Department of Human Physiology and Centre for Neuroscience, Flinders University, Adelaide, SA 5042, Australia. E-mail: damien.keating@flinders.edu.auAbbreviations used: 5-HT, 5-hydroxytryptophan; CG, cytotoxic granules; CTL, cytotoxic T lymphocyte; EC, enterochromaffin; ELKS, protein rich in the amino acids E, L, K, S; IS, immunological synapse; RIM2, Rab3-interacting molecule 2; SNARE, N-ethyl maleimidesensitive fusion protein attachment protein receptor; TIRF, total internal reflection fluorescence.